Selvita SA
WSE:SLV
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
50.4
72
|
Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SLV stock under the Base Case scenario is 78.26 PLN. Compared to the current market price of 55.5 PLN, Selvita SA is Undervalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Selvita SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SLV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Selvita SA
Balance Sheet Decomposition
Selvita SA
Current Assets | 120m |
Cash & Short-Term Investments | 14.8m |
Receivables | 89.6m |
Other Current Assets | 15.6m |
Non-Current Assets | 522.7m |
Long-Term Investments | 62.8m |
PP&E | 328.6m |
Intangibles | 118.8m |
Other Non-Current Assets | 12.5m |
Current Liabilities | 106.8m |
Accounts Payable | 39.3m |
Accrued Liabilities | 8.1m |
Other Current Liabilities | 59.4m |
Non-Current Liabilities | 219.9m |
Long-Term Debt | 180.4m |
Other Non-Current Liabilities | 39.5m |
Earnings Waterfall
Selvita SA
Revenue
|
329m
PLN
|
Cost of Revenue
|
-70.1m
PLN
|
Gross Profit
|
258.9m
PLN
|
Operating Expenses
|
-207.6m
PLN
|
Operating Income
|
51.3m
PLN
|
Other Expenses
|
-3.9m
PLN
|
Net Income
|
47.4m
PLN
|
Free Cash Flow Analysis
Selvita SA
PLN | |
Free Cash Flow | PLN |
SLV Profitability Score
Profitability Due Diligence
Selvita SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Selvita SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
SLV Solvency Score
Solvency Due Diligence
Selvita SA's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Score
Selvita SA's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SLV Price Targets Summary
Selvita SA
According to Wall Street analysts, the average 1-year price target for SLV is 69.92 PLN with a low forecast of 58.58 PLN and a high forecast of 82.64 PLN.
Dividends
Current shareholder yield for SLV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Selvita SA engages in the discovery, regulatory studies, as well as research and development. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 878 full-time employees. The company went IPO on 2019-10-16. The firm is engaged in providing multidisciplinary solutions supporting customers and projects within area of drug discovery, regulatory studies, as well as research and development. The company offers its clients drug discovery support at every stage of the early discovery phase up to preclinical research, from target validation up to the selection of a clinical candidate. Also, it offers services at every stage of the drug discovery process in the field of drug testing and bioanalytical analyses, from development and validation of methods, stability studies, to routine quality control testing. The firm cooperates with numerous research institutes and universities from Europe and the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one SLV stock under the Base Case scenario is 78.26 PLN.
Compared to the current market price of 55.5 PLN, Selvita SA is Undervalued by 29%.